Overview

A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg

Status:
Completed

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

Summary

To establish the bioequivalence between Glucobay ODT (Orally Disintegrating Tablet) 100 mg taken without or with water and the Glucobay standard tablet 100 mg taken with water.

Phase:

Phase 1

Details

Lead Sponsor:

Bayer

Treatments:

Acarbose